The FDA Falls Short in Zantac Cancer Testing

How many other drugs whose safety we take for granted may cause cancer and are on the market?

Tuesday, July 28, 2020 - The public is becoming increasingly concerned that individuals that took Zantac or other forms of ranitidine regularly to treat bouts of heartburn and acid reflux disease may have developed cancer of the stomach, bladder, prostate, or another type of the disease. Reputable online publications and the US Food and Drug Administration (FDA) are unanimous that people who used the product get checked by a physician at the first sign of pain, lethargy, or other cancer early warning symptoms. Before the official FDA recall earlier this year, Zantac was the leading heartburn and acid reflux medicine in the world. About 15 million people per year are estimated to have taken Zantac regularly, many of whom may now be walking around with a cancer time bomb ticking inside of them. Zantac Antacid cancer attorneys offer a free consultation to families and individuals suffering from stomach cancer due to taking Zantac for stomach discomfort. At the heart of the Zantac, ranitidine cancer scare is a naturally occurring compound called N-Nitrosodimethylamine (NDMA). Health experts knew for decades that medications like ranitidine, blood pressure medicine, and also SGL type 2 diabetes medications contained low levels of NDMA believed to be safe for human consumption. In late 2019, the FDA became concerned that levels of potentially carcinogenic NDMA, up to 2500 times the acceptable amount, had been found during routine drug testing by online pharmacy Valisure. Legal Reader.com describes the chemical as "N-Nitrosodimethylamine, better known by its acronym - NDMA, is a highly toxic organic compound that, in specific quantities, has the potential to become carcinogenic. It is found most commonly in drinking water, and in low quantities in products such as curated meats, tobacco, and beer."

Health experts continue to be puzzled over the exact reason that NDMA quantities increase to dangerous levels and are looking at high storage temperatures, NDMA's interaction with nitrates in the stomach, and possible contamination at the source of overseas drug manufacturing plants for an explanation. Heartburn sufferers were advised by the US FDA to switch to Nexium, Prevacid, or Prilosec, for heartburn relief because they have tested negative for elevated NDMA, but even those drugs have may have exceedingly high risks of their own. Nexium, Prevacid, and Prilosec are protein inhibitor drugs (PPI) that work by blocking the production of stomach acid. Health experts feel that properly functioning stomach acid is essential for killing viruses like COVID19 that is currently plaguing the world. Heartburn sufferers, in my opinion, should look to make dietary and lifestyle changes including eating less spicy foods, eliminating stress, and exercising more to treat their discomfort after consulting their physician.

The safety of consumer drugs like Zantac and other consumer drugs and products is taken for granted by consumers in the US who think that if it is on the market it must have gone through thorough testing and is safe. That stance is not true unfortunately as the FDA has instituted more lenient "fast-track" approval for drug companies that only have to show that their product is similar to one already on the market. Cancer's 20-year latency period makes post-market studies and testing irrelevant as is the case with Zantac cancer. Zantac cancer is only now starting to show up, two decades after the drug was approved by the FDA.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.